USPTO Director Squires's First Patents: Crypto Software and Diagnostic Methods
Briefly

USPTO Director Squires's First Patents: Crypto Software and Diagnostic Methods
"On September 23, 2025, John A. Squires-just sworn in as the 60th Director of the USPTO-issued his first public act. In his first official act as USPTO Director, John Squires held a ceremonial signing of two newly issued patents-one covering diagnostic methods using a discovered antibody and the the other a blockchain-based resource allocation FinTech software. U.S. Patent Nos. 12,419,201 and 12,419,202."
"These choices appear to me a deliberate signal. Squires highlighted technologies that sit squarely within the domains that the Supreme Court and Federal Circuit have restricted most heavily over the past decade via the expanded patent eligibility doctrine of Alice and Mayo. In his remarks, Squires emphasized his intended signal: "the U.S. Patent Office is open for business, especially for the technologies of tomorrow.""
John A. Squires was sworn in as the 60th Director of the United States Patent and Trademark Office on September 23, 2025. His first official act was a ceremonial signing of two newly issued patents. The patents cover diagnostic methods using a discovered antibody and a blockchain-based resource allocation FinTech software. The patents are U.S. Patent Nos. 12,419,201 and 12,419,202. Those patent selections function as a deliberate signal endorsing technologies that have been heavily restricted by Supreme Court and Federal Circuit rulings under the Alice and Mayo patent eligibility doctrines over the past decade. A public statement accompanied the signing: "the U.S. Patent Office is open for business, especially for the technologies of tomorrow."
Read at Patently-O
Unable to calculate read time
[
|
]